AGP Executive Report
Last update: 2 hours agoEbola Alert: Nigeria has confirmed a travel-related Bundibugyo Ebola case; the patient is isolated and health teams are tracing 44 contacts. Ghana has stepped up airport screening as regional officials strengthen outbreak readiness. Medication Safety: The FDA’s Class II recall covers 22 vials of compounded tirzepatide and one NAD+ injection over sterility concerns. The products were distributed nationwide; the recall does not include brand-name Mounjaro or Zepbound. Women’s Health: A new survey found 7 in 10 women did not recognize, or were unsure about, perimenopause symptoms—often because the transition can begin before 45 and symptoms vary widely. Mental Health: Long COVID continues to leave science communicator Physics Girl coping with severe symptoms and unanswered questions. Separately, clinicians warn that stigma around psychedelics could hinder access if the drugs gain approval for mental health treatment. Infectious Disease: Wisconsin’s measles total has reached 289, with a new case in Richland County; nearly 100 norovirus cases have also been reported at a Kansas elementary school. Everyday Stress: Money is a stressor for 65% of Americans in a recent survey; experts suggest facing the source of worry, challenging negative beliefs and making a plan.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
